{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Chandan Healthcare Ltd
Chandan Healthcare Ltd is Rated Hold
Chandan Healthcare Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 01 July 2026. While this rating change occurred recently, the analysis and financial metrics discussed here reflect the company’s current position as of 05 July 2026, providing investors with the most up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Chandan Healthcare Ltd Technical Momentum Shifts Amid Market Volatility
Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade from a Sell to a Hold rating by MarketsMOJO on 1 July 2026, the stock’s price action and technical indicators reveal a complex picture that investors should carefully analyse.
Chandan Healthcare Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Signals
Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. Despite a day decline of 2.42%, the stock’s weekly and monthly technical indicators suggest a cautiously optimistic outlook, contrasting with its recent price performance and broader market returns.
Chandan Healthcare Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift
Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a notable 4.00% gain on 29 Jun 2026, the stock’s technical indicators present a complex picture, reflecting both cautious optimism and lingering bearish pressures.
Chandan Healthcare Ltd is Rated Sell
Chandan Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.
Chandan Healthcare Ltd Faces Bearish Momentum Amid Technical Downturn
Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend. The stock’s recent performance contrasts sharply with broader market indices, reflecting mounting pressure on its valuation and investor sentiment.
Chandan Healthcare Ltd is Rated Sell
Chandan Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Chandan Healthcare Ltd is Rated Sell
Chandan Healthcare Ltd is currently rated Sell by MarketsMOJO, with this rating last updated on 30 May 2026. While the rating was assigned on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Chandan Healthcare Q4 FY26: Strong Profit Growth Masks Margin Pressure
Chandan Healthcare Ltd., a North India-based diagnostic services provider operating pathology and radiology testing facilities, reported its March quarter (Q4 FY26) results with consolidated net profit surging 64.76% year-on-year to ₹6.92 crores. However, the micro-cap company with a market capitalisation of ₹565.00 crores witnessed its stock tumble 6.02% following the results announcement, closing at ₹228.70 on June 01, 2026, as investors focused on sequential margin contraction despite robust topline expansion.
Why is Chandan Healthcare Ltd falling/rising?
On 24-Dec, Chandan Healthcare Ltd witnessed a significant price rise of 8.97%, closing at ₹320.10, reflecting robust short-term buying interest and technical strength despite mixed longer-term returns.
Why is Chandan Healthca falling/rising?
As of 17-Nov, Chandan Healthcare Ltd is currently priced at 337.30, reflecting a 7.63% increase and strong upward momentum. However, a significant drop in delivery volume raises concerns about the sustainability of this price increase despite the stock's recent outperformance.
How has been the historical performance of Chandan Healthca?
Chandan Healthca has experienced significant growth from March 2023 to March 2025, with net sales increasing from 136.89 Cr to 230.12 Cr and profit after tax rising from 3.59 Cr to 23.52 Cr, despite facing challenges in cash flow management. Total assets grew from 76.12 Cr to 210.62 Cr, indicating a solid financial position.
Why is Chandan Healthca falling/rising?
As of 11-Nov, Chandan Healthcare Ltd's stock price is at 311.70, down 6.11% and underperforming its sector by 5.44%. Despite trading above longer-term moving averages, it has seen a significant drop in investor participation and a decline of 6.37% over the past week, contrasting with the broader market's modest gains.
Why is Chandan Healthca falling/rising?
As of 23-Oct, Chandan Healthcare Ltd's stock price is Rs. 339.00, up 4.95% and reaching a new all-time high. Despite a decline in delivery volume, the stock has significantly outperformed the Sensex over the past week and month, indicating strong investor interest.
Why is Chandan Healthca falling/rising?
As of 13-Oct, Chandan Healthcare Ltd's stock price has risen to Rs. 302.40, marking a 5.0% increase and reaching a new all-time high. The stock has significantly outperformed the Sensex and shows strong investor demand, with a notable rise in trading volume.
Why is Chandan Healthca falling/rising?
As of 08-Oct, Chandan Healthcare Ltd's stock price is rising to 261.25, reflecting a 4.98% increase and strong performance compared to its sector. The stock is trading above key moving averages and has seen a significant rise in investor participation, indicating robust demand and positive sentiment.
Why is Chandan Healthca falling/rising?
As of 29-Sep, Chandan Healthcare Ltd's stock price is at 232.35, down 2.52%, with a significant drop in investor participation. Despite recent volatility, the stock has outperformed the Sensex over the month, indicating resilience compared to the broader market.
Why is Chandan Healthca falling/rising?
As of 24-Sep, Chandan Healthcare Ltd is priced at 248.80, having increased by 0.36% with a one-week return of +10.58%, outperforming the Sensex's -1.08%. Despite strong performance and adequate liquidity, a 17.06% drop in delivery volume raises concerns about the sustainability of this upward trend.
Why is Chandan Healthca falling/rising?
As of 23-Sep, Chandan Healthcare Ltd is showing strong upward momentum with a current price of 247.90, up 5.0%, and significantly outperforming its sector. The stock has seen a notable increase in investor participation and has gained 11.32% over the past week, contrasting positively with the broader market's slight decline.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
